These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 19029950)

  • 41. Generation and Use of Merlin-Deficient Human Schwann Cells for a High-Throughput Chemical Genomics Screening Assay.
    Petrilli AM; Fernández-Valle C
    Methods Mol Biol; 2018; 1739():161-173. PubMed ID: 29546707
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Merlin-deficient human tumors show loss of contact inhibition and activation of Wnt/β-catenin signaling linked to the PDGFR/Src and Rac/PAK pathways.
    Zhou L; Ercolano E; Ammoun S; Schmid MC; Barczyk MA; Hanemann CO
    Neoplasia; 2011 Dec; 13(12):1101-12. PubMed ID: 22247700
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The neurofibromatosis type 2 gene product, merlin, reverses the F-actin cytoskeletal defects in primary human Schwannoma cells.
    Bashour AM; Meng JJ; Ip W; MacCollin M; Ratner N
    Mol Cell Biol; 2002 Feb; 22(4):1150-7. PubMed ID: 11809806
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Merlin/NF2 regulates angiogenesis in schwannomas through a Rac1/semaphorin 3F-dependent mechanism.
    Wong HK; Shimizu A; Kirkpatrick ND; Garkavtsev I; Chan AW; di Tomaso E; Klagsbrun M; Jain RK
    Neoplasia; 2012 Feb; 14(2):84-94. PubMed ID: 22431917
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tumor suppressor schwannomin/merlin is critical for the organization of Schwann cell contacts in peripheral nerves.
    Denisenko N; Cifuentes-Diaz C; Irinopoulou T; Carnaud M; Benoit E; Niwa-Kawakita M; Chareyre F; Giovannini M; Girault JA; Goutebroze L
    J Neurosci; 2008 Oct; 28(42):10472-81. PubMed ID: 18923024
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The neurofibromatosis 2 protein, merlin, regulates glial cell growth in an ErbB2- and Src-dependent manner.
    Houshmandi SS; Emnett RJ; Giovannini M; Gutmann DH
    Mol Cell Biol; 2009 Mar; 29(6):1472-86. PubMed ID: 19103750
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human schwannomas express activated platelet-derived growth factor receptors and c-kit and are growth inhibited by Gleevec (Imatinib Mesylate).
    Mukherjee J; Kamnasaran D; Balasubramaniam A; Radovanovic I; Zadeh G; Kiehl TR; Guha A
    Cancer Res; 2009 Jun; 69(12):5099-107. PubMed ID: 19509233
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Microarray analysis of gene expression in vestibular schwannomas reveals SPP1/MET signaling pathway and androgen receptor deregulation.
    Torres-Martin M; Lassaletta L; San-Roman-Montero J; De Campos JM; Isla A; Gavilan J; Melendez B; Pinto GR; Burbano RR; Castresana JS; Rey JA
    Int J Oncol; 2013 Mar; 42(3):848-62. PubMed ID: 23354516
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Emerging therapeutic targets in schwannomas and other merlin-deficient tumors.
    Ammoun S; Hanemann CO
    Nat Rev Neurol; 2011 Jun; 7(7):392-9. PubMed ID: 21647202
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of SIRT2 in merlin/NF2-mutant Schwann cells triggers necrosis.
    Petrilli A; Bott M; Fernández-Valle C
    Oncotarget; 2013 Dec; 4(12):2354-65. PubMed ID: 24259290
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential gene expression between human schwannoma and control Schwann cells.
    Hanemann CO; Bartelt-Kirbach B; Diebold R; Kämpchen K; Langmesser S; Utermark T
    Neuropathol Appl Neurobiol; 2006 Dec; 32(6):605-14. PubMed ID: 17083475
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Overexpression of ErbB2 and ErbB3 receptors in Schwann cells of patients with Charcot-Marie-tooth disease type 1A.
    Massa R; Palumbo C; Cavallaro T; Panico MB; Bei R; Terracciano C; Rizzuto N; Bernardi G; Modesti A
    Muscle Nerve; 2006 Mar; 33(3):342-9. PubMed ID: 16307437
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro studies of steroid hormones in neurofibromatosis 1 tumors and Schwann cells.
    Fishbein L; Zhang X; Fisher LB; Li H; Campbell-Thompson M; Yachnis A; Rubenstein A; Muir D; Wallace MR
    Mol Carcinog; 2007 Jul; 46(7):512-23. PubMed ID: 17393410
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sequestration and segregation of receptor kinases in epithelial cells: implications for ErbB2 oncogenesis.
    Carraway CA; Carraway KL
    Sci STKE; 2007 Apr; 2007(381):re3. PubMed ID: 17426346
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nf2 Mutation in Schwann Cells Delays Functional Neural Recovery Following Injury.
    Truong K; Ahmad I; Jason Clark J; Seline A; Bertroche T; Mostaert B; Van Daele DJ; Hansen MR
    Neuroscience; 2018 Mar; 374():205-213. PubMed ID: 29408605
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cross-talk between growth factor and purinergic signalling regulates Schwann cell proliferation.
    Stevens B
    Novartis Found Symp; 2006; 276():162-75; discussion 175-80, 233-7, 275-81. PubMed ID: 16805429
    [TBL] [Abstract][Full Text] [Related]  

  • 57. NF2 deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions.
    Lallemand D; Curto M; Saotome I; Giovannini M; McClatchey AI
    Genes Dev; 2003 May; 17(9):1090-100. PubMed ID: 12695331
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Actin-rich protrusions and nonlocalized GTPase activation in Merlin-deficient schwannomas.
    Flaiz C; Kaempchen K; Matthies C; Hanemann CO
    J Neuropathol Exp Neurol; 2007 Jul; 66(7):608-16. PubMed ID: 17620986
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of the tumor suppressor genes NF2, 4.1B, and TSLC1 in canine meningiomas.
    Dickinson PJ; Surace EI; Cambell M; Higgins RJ; Leutenegger CM; Bollen AW; LeCouteur RA; Gutmann DH
    Vet Pathol; 2009 Sep; 46(5):884-92. PubMed ID: 19429976
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The NF2 tumor suppressor regulates microtubule-based vesicle trafficking via a novel Rac, MLK and p38(SAPK) pathway.
    Hennigan RF; Moon CA; Parysek LM; Monk KR; Morfini G; Berth S; Brady S; Ratner N
    Oncogene; 2013 Feb; 32(9):1135-43. PubMed ID: 22525268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.